Health Economics Group 2016

Similar documents
Step by step guide to economic evaluation in cancer trials

Utilisation of medical services

Case Study New Hospital Development : Project Management

Lima, May Prepared by Marc Robinson

Methodology to assess the cost impact of PMB benefit definitions

Family Value Package. Your guide to. Questions? Need Advice? Our consultants are available to help.

Freedom Package. Key Facts Sheet

The politics of health Vernon Collins Oration The Royal Children s Hospital Melbourne

KENYA DYNAMIC HEALTH SERVICE COSTING MODEL

Performance Pillar. P1 Performance Operations. 24 November 2010 Wednesday Morning Session

12TH OECD-NBS WORKSHOP ON NATIONAL ACCOUNTS MEASUREMENT OF HEALTH SERVICES. Comments by Luca Lorenzoni, Health Division, OECD

What can Health Economics do for you?

Established Family Package. Key Facts Sheet

The Economy Wide Benefits of Increasing the Proportion of Students Achieving Year 12 Equivalent Education

How to monitor progress to guaranteed waiting time targets

for example, Medicare reimbursement rates, you're just looking at this issue from Medicare's point of view, what's the cheapest way to go about doing

Category A: Costs & Savings Reporting Guidance

Cover Summary For Everyday - Comprehensive. Hospital cover. What does it mean? This cover is only available for singles and couples.

Options to reduce pressure on private health insurance premiums by addressing the growth of private patients in public hospitals

COMMON DETERMINANTS AND COST- DRIVERS OF PROVINCIAL GOVERNMENT HEALTH EXPENDITURES

Frequently Asked Questions Contents

The benefits of the PBS to the Australian Community and the impact of increased copayments

Health Information Technology and Management

ERM , Getzen Economics and Financing (Sec. 5.4, 5.5)

Going to hospital. What you need to know

Freedom Package. Key Facts Sheet

Standard for informed financial consent

Universal health coverage roadmap Private sector engagement to improve healthcare access

Welcome to Aetna Global Benefits. Benefits. International Healthcare Plan EU (11/09)

COMMISSION DECISION. of

Methods of Financial Costing Analysis. Jeremy Lauer, WHO (Geneva)


Public Healthcare. Economics 325 Martin Farnham

HOSPITAL SELF-PAY CASH PLAN

Consumer-Driven Health Plans:

A guide to Bupa Global s pricing philosophy

This complete report including detailed tables and methodology can be found at

The Cost of Specialty Drugs: Payer Perspectives

HEALTHCARE COSTS AND OUTCOMES MODEL USER GUIDE

Booklet A1: Cost and Expenditure Analysis

Cover Summary For Security - Essentials. Hospital cover. What does it mean?

Prescription Drugs Spending Distribution and Cost Drivers. Steve Kappel January 25, 2007

Sensitivity = NPV / PV of key input

Overview of Reimbursement Strategies for Novel Medical Technologies

Quality of Health Care and the Design of the Basic Benefit Package Lessons from Overseas

FEDERAL BUDGET

Economics Concepts Overview

ENHANCING VICTORIA S ECONOMIC PERFORMANCE AND PRODUCTIVITY. Cbus is pleased to provide some brief comments in relation to the discussion paper.

Hospital Alternative Reimbursement Models, and DRGs

Presentation to UBS Australasia Conference November Attached presentation delivered by nib at the UBS Australasia Conference (8 November 2016).

Policy document and members guide

Multinational Comparisons of Health Systems Data, Roosa Tikkanen The Commonwealth Fund

Long-term Funding of Health and Ageing

Combined Insurance Claim Form

Important Instructions on How to Complete the Attached Claim Form and How We Assess Claims

Members Health Fund Alliance

Cost Analysis and Efficiency in Health: Lessons of Experience

Trends in Australian government health funding by age: a fiscal incidence analysis

Medical and Eligibility User Guide V2.2 for Medical Practitioners ECLIPSE. humanservices.gov.au

Randwick Waverley Community Transport

Multinational Comparisons of Health Systems Data, 2016

Workshop for Shelter Scotland s Homelessness Conference. Karen Hancock Economist Long- Run Economics Ltd and Pro Bono Economics

PERSONAL INJURY CLAIM FORM

Belgian Health Care System. Jo DE COCK - CEO National Institute Health & Disability Insurance (NIHDI) Brussels 9 November 2011

Managing medical cost inflation: global successes & failures

We work for you Not An Insurance Company

Economic Evaluations in Health An introduction for clinicians, researchers, and policy makers

Controlling Healthcare Costs through Innovative Methods - Analytics

The Power of YOU! your personal guide to consumer-directed healthcare

Financial Planning. Patient Education. For a liver transplant

Mid Cheshire Hospitals NHS Foundation Trust Annual Members Meeting

Initiative Options for Simulation Scenarios

The Dialogue Podcast Transcript Private Health Insurance

Secondary Insurance Information: Name of Insured: Relationship to Insured: Self Spouse Child Other

Costs to Britain of workplace injuries and work-related ill health: 2009/10 update

Established Family Package

An investment approach to welfare applying traditional actuarial techniques in new fields

Gold Hospital (No Pregnancy) GNO, GN1 & GN2- $0, $250 & $500 annual excess

A guide for injured workers. Introducing WorkSafe. April 2014

Lithuania. How does the country rank in the EU? Health. Overall Findings. Need Lithuania has a high need for policy reform, assessed by the experts

Cover Summary For New Families Essentials

*This document is searchable.

GUIDING PRINCIPLES FOR PRIVATE HEALTH REFORM

Controlling Hospital Charges for Self-funded Plans

Being unprepared for a medical emergency can cost you thousands of $$ out of pocket.

IICCI Short Market Overviews. The Healthcare Industry in India

Guidelines for cost analyses of new medicines and indications in the hospital sector

A guide for injured workers. Introducing WorkSafe. September 2011

Economic impact of NHS spending in the Black Country. 21 July 2017

Sutter Medical Network

Priority Series PRIORITY SERIES

Twinning, social-statistics Israel Denmark. Social statistics

Overseas Student Health Cover

REPORT ON ANALYSIS OF MEDICAL SCHEMES CLAIMS DATA: A FOCUS ON FUNDERS VERSION: 15 DECEMBER 2017

Transition Guide for. Fifth Edition Table of Contents

Cover Summary SmartPlus

Accessing Healthcare in the UK

MOVING FROM EVALUATION TO VALUATION

The role of data analytics in present and future claims cost containment

A CONSUMER S GUIDE TO CANCER INSURANCE

Transcription:

Introduction to CostEffectiveness Analysis in Health Health Economics Short Course For more information and course dates, please visit our website: http://go.unimelb.edu.au/8eqn Or email us: health-economics@unimelb.edu.au Overview Module 2 Identifying, Measuring, Valuing and Analysing Costs 1. What is a cost? 2. Identifying costs 3. Measuring costs 4. Valuing costs Centre for Health Policy Melbourne School of Population and Global Health What is a cost? Cost to be obtained at a price of to involve in expenditure of to be required to be laid out or suffered or lost Financial cost the total money expenditure required to achieve a goal Economic cost = opportunity cost: what must be sacrificed in order to achieve a goal; the value of the resources in their next best use if you do A, you cannot do B the cost of doing A, is the foregone value of B Health Economics Group 216 5. Analysing costs Economic costs The costs are the economic inputs required to produce a certain intervention Four factors of production Labour (doctors, admin, physiotherapists, patient time..) Consumables (drugs, educational materials, heating,..) Capital (buildings, machines,.) Land Page 1 of 6

How are resources/costs categorized according to perspective/sector? Study Viewpoint Societal: all costs to whomsoever they accrue Total Costs Health Sector: costs to the government and private sector Government: Commonwealth and/or State/Territory Third Party Funder: public or private (insurance company,..) Healthcare Provider: Hospital, GP Patients/Carers: out of pocket expenses, travel, waiting time Other sectors: (Social Services; Justice;..) Study Viewpoint Societal perspective is ideal Policy makers often want a narrower perspective budgets are fixed and there are incentives to shift costs Examples of cost shifting; When evaluating whether to centralize all cancer services to make efficiency savings we should consider the additional travel costs to patients and family Impact of GP co-payments (Federal) on ED and hospital admissions (State) Patient & Family Healthcare Sector Health professionals time Admin support Future hospitalisations Capital costs Light, heat, cleaning Other Sectors Productivity Crime costs Housing Education Social Services. Travel costs Treatment time Waiting time Out-of-pocket payments Home modifications Nursing support Process of Costing Three steps: 1. Identification of the appropriate costs to include in the appraisal (i.e. the inclusion/exclusion criteria based on perspective adopted) 2. Measurement of the quantity (in appropriate units) of resources used and saved by the program alternatives 3. Valuation of the resources used (and saved) in appropriate prices per unit for comparison Identifying Resources Important to be able to accurately describe all the elements/resources that are needed to make a program work in its intended form Downstream resource use may also differ between programs and this needs to be recorded/estimated We need to know about the treatment and disease pathways to identify all the resource implications (for both intervention and comparator) Future hospitalisations, GP visits, drug use, At home support services, carer time, home modifications, Health Economics Group 216 Page 2 of 6

Scaling up Fixed versus Variable costs Fixed costs: accrued no matter how big the program (educational materials, machines, program set-up costs) We record the costs involved in this Pilot Project Variable costs: rise the bigger the program - more patients increase the total cost (drugs, GP time) When predicting the cost of a program we want to estimate the program cost for its intended form We are trying to inform a future decision not a past decision Variable Costs Variable Costs Intended Program Fixed Cost But we want to predict the costs involved in this Fixed Cost Important to separate fixed and variable costs Collecting resources use information is costly Many different instruments are used to collect resource use Focus on the key cost drivers Weigh up the likely importance of the cost versus the cost of collecting Make use of routinely collected data wherever possible to estimate the costs A UK project created an open-access instrument database http://www.dirum.org/ The idea is to standardise questions where possible Link to PBS, MBS records Linked hospital data for future hospitalisations Use patients postcode and treatment postcode to estimate travel time One of the DIRUM instruments for hip replacement procedures Health Economics Group 216 Not only health care usage but also other social service use Page 3 of 6

Valuing Resources Valuing Resources Once we have estimated the resources used within and after the program we then have to place a value on each resource How valuable ($) is; 1 hr of a GP s time? the use of a operating theatre for 1 hr? 1 hr of a volunteer's time? preventing an A&E visit? reducing a patient s treatment time by 1 hr? reducing family and friends travel time by 2 hrs? Opportunity Cost how valuable would the resources be if they were used in the next best process instead? Often the price paid for a resource represents a reasonable estimate of its opportunity cost; but not always Volunteer time; Volunteer s could be engaged in some other valuable activity Patient & Family travel time; how valuable do patients regard having services close to their home? Volunteer and patient time often costed at 1/3 of average wage Valuing Resources Types of costing approaches Some Australian health cost information Independent Hospital Pricing Authority https://www.ihpa.gov.au/ Manual of Resource and their Associated Cost from DoHA; for use in PBAC submissions http://www.pbs.gov.au/info/industry/useful-resources/manual Victorian hospital cost information https://www2.health.vic.gov.au/hospitals-and-health-services/ funding-performance-accountability/activity-based-funding/costweight-calculators Micro costing Ingredients method Bottom up costing Key issues in costs Costs over time $6 Now 1985 1995 Health Economics Group 216 25 Less Costly to collect Hidden Uncertainty Less Accurate $3 Australian Consumer Price Index 1975 Average per day DRG cost weight MBS fee PBS fee $9 Costs Even though we expect the nominal wage of a GP to increase over time we consider the current GP wage Budgets will normally also increase with inflation 1965 Key issues in costing: Discounting All ($) values should be the current resource cost rather than their past cost We ignore inflation - covert all costs into real dollars based on what a current dollar is worth 1955 Top down Ignores variation E.g. number of tests ordered, time with counsellor, dosing minutes, visits Type and number of medications More Accurate More Costly to collect 12 1 8 6 4 2 1945 Macro costing 215 1 3 2 Time period (years) 4 Treatment A- surgery Treatment B- fitness program for five years Page 4 of 6

Key issues in costing: Discounting Key issues in costing: Discounting Delaying costs is valuable as these funds could be invested elsewhere now and gain returns Total Costs Treatment A- $9 Treatment B- $1 Costs over time $9 We wish to convert future costs into the equivalent cost today = present value Costs $6 How much would you need to save & invest today in order to be able to pay for these future costs tomorrow? $3 We also discount future outcomes Now 1 2 3 Time period (years) 4 Discounted Costs (at 5% annual rate PBAC recommended) Treatment A- $9 Treatment B- $95 Discounted costs for Treatment B Analysing Costs Importance of discounting Present Value ($) Difference between 5% (AUS) and 3.5% (UK) discount rates for $1 of future cost savings Costs are often skewed - a few patients cause some very large costs But these costs are important as they can strongly influence the total cost of the intervention 1 9 8 7 6 5 4 3 2 1 The median (middle cost) is NOT a good indicator 3.5% 5% The mean cost is often a lot higher than the median In cost-effectiveness we mostly use the MEAN as this is what is relevant to a funder 5 1 15 2 Year when the $1 is incurred US Medical Expenditure Survey 214 We estimate the costs from Individual US Medical Expenditure in 214 15 Intended Program And use these estimates to predict the cost of 29 214 $US in thousands Approximately 5% of the sample accounted for over 56% of the total medical costs recorded Health Economics Group 216 More 27 25 23 19 21 17 15 13 9 11 7 5 Pilot Project Median = $US 1 Mean $US 735 3 5 1 Number of People 2 1 Analysing Costs (capturing the uncertainty) Slightly off pilot estimates can result in large differences in the projected versus actual costs of the intended program! Knowing the uncertainty allows us to quantify the financial risk to budgets and the risk of whether it is cost-effective Page 5 of 6

US Medical Expenditure 214 Survey Sample Mean $US 735 (Uncertainty around the true mean).18 There is a chance that the true mean is actually either lower or higher.14.12.1.8.6 $US 213 billion Total Medical Expenditure if the true average cost was $US 77 $US 237 billion.4.2 Total Medical Expenditure if the true average cost was $US 69.16 % Analysing Costs (capturing the uncertainty) 67 69 71 73 75 77 79 81 83 A $US 24 billion difference True Mean $US Analysing Costs (Sensitivity) It is wise to undertake a number of sensitivity (what if) tests around some of the key assumptions Reporting Costs Key assumptions regarding the costs should be clearly stated and justified What if fewer/more patients get seen than expected? Fixed and variable costs should be reported separately What if a more effective intervention becomes available in the near future? Cost should be broken down into components (clearly state who will bear each cost) What if a machine lasts for fewer years than expected? The mean and uncertainty (95% confidence intervals) around the costs along with other sensitivity analysis should be reported Health Economics Group 216 Page 6 of 6